ESC 22 Late-breaker Discussion: The REVIVED Trial

Published: 29 Aug 2022

  • Views:

    Views Icon 1249
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

ESC Congress 22 — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) sat down with Prof Divaka Perera (Guy's & St Thomas' NHS Foundation Trust) joins us to discuss the findings of the REVIVED trial (NCT01920048).

The rationale of the REVIVED study was to evaluate whether percutaneous coronary intervention (PCI) combined with optical medical therapy would improve survival and reduce hospitalisation in patients with heart failure, as compared to optimal medical therapy alone.

Recorded onsite at ESC Congress 22, Barcelona.

Editor: Mirjam Boros, Jordan Rance

Videographer: Mike Knight, Dan Brent, Tom Green, Oliver Miles